Denmark-based Novo Nordisk filed multiple lawsuits June 20 against spas and clinics across four states that allegedly marketed and sold unapproved compounded versions of the drugmaker’s popular Ozempic and Wegovy products.
Read the full post on Becker's Hospital Review - Healthcare News
